Importantly, FAK inhibitors are proposed as promising therapeutic approaches for pancreatic cancers, showing inhibition not only of metastasis, but also tumor growth, stemness, therapy resistance, and interactions with the tumor microenvironment. Here, PTK2 is linked to neoplasm.